BPC-157 (Pure Pentadecapeptide)
Comprehensive sequence profile, chromatographic purity benchmarks, and pathway analysis for BPC-157, a synthetic 15-amino acid gastric pentadecapeptide investigated in VEGF expression and cytoprotective assays.
Sequence Architecture & Structural Stability
BPC-157 is a synthetic pentadecapeptide consisting of 15 amino acid residues (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) derived from a protective protein sequence isolated from human gastric juice. Unlike linear sequences susceptible to rapid enzymatic cleavage, the proline-rich backbone (Pro-Pro-Pro) confers high structural stability in acidic and aqueous assay buffers.
Primary In-Vitro Research Pathways
Laboratory investigations utilize BPC-157 to evaluate multi-pathway cellular migration, cytoskeletal organization, and vascular signaling:
- VEGFR2 Activation & Angiogenesis: Upregulates vascular endothelial growth factor receptor 2 (VEGFR2) internalization and downstream endothelial nitric oxide synthase ($\text{eNOS}$) phosphorylation.
- FAK–Paxillin Signaling: Accelerates fibroblast and tenocyte outgrowth in scratch-wound assays via focal adhesion kinase (FAK) and paxillin phosphorylation.
- Nitric Oxide (NO) System Modulation: Counteracts both NOS-inhibition ($\text{L-NAME}$) and excessive NO-donor stress in vascular endothelial preparations.
Analytical Testing & Handling
| Parameter | Analytical Benchmark |
|---|---|
| RP-HPLC Purity | $\ge 99.7\%$ (214 nm UV detection) |
| ESI-MS Identity | $1419.5\text{ g/mol}$ ($\pm 0.5\text{ Da}$) |
| Lyophilization Moisture | $< 1.0\%$ Karl Fischer titration |
| Endotoxin Limit | $< 0.05\text{ EU/mg}$ |
Store lyophilized vials nitrogen-purged and sealed at $-20^\circ\text{C}$. After reconstitution with $0.9\%$ bacteriostatic water, maintain at $2^\circ\text{C}$ to $8^\circ\text{C}$ and utilize within $30$ to $45$ days.
Related Research Requisition
Inspect batch lot #NL-BPC10 chromatograms and specification data on the BPC-157 Product Page[cite: 13].